253 related articles for article (PubMed ID: 35195673)
1. Visual-tactile shape perception in the visually restored with artificial vision.
Stiles NRB; Weiland JD; Patel VR
J Vis; 2022 Feb; 22(2):14. PubMed ID: 35195673
[TBL] [Abstract][Full Text] [Related]
2. Multisensory perception in Argus II retinal prosthesis patients: Leveraging auditory-visual mappings to enhance prosthesis outcomes.
Stiles NRB; Patel VR; Weiland JD
Vision Res; 2021 May; 182():58-68. PubMed ID: 33607599
[TBL] [Abstract][Full Text] [Related]
3. Five-Year Safety and Performance Results from the Argus II Retinal Prosthesis System Clinical Trial.
da Cruz L; Dorn JD; Humayun MS; Dagnelie G; Handa J; Barale PO; Sahel JA; Stanga PE; Hafezi F; Safran AB; Salzmann J; Santos A; Birch D; Spencer R; Cideciyan AV; de Juan E; Duncan JL; Eliott D; Fawzi A; Olmos de Koo LC; Ho AC; Brown G; Haller J; Regillo C; Del Priore LV; Arditi A; Greenberg RJ;
Ophthalmology; 2016 Oct; 123(10):2248-54. PubMed ID: 27453256
[TBL] [Abstract][Full Text] [Related]
4. Retinal Prosthesis System for Advanced Retinitis Pigmentosa: A Health Technology Assessment Update.
Health Quality Ontario
Ont Health Technol Assess Ser; 2017; 17(13):1-62. PubMed ID: 29201260
[TBL] [Abstract][Full Text] [Related]
5. Rehabilitation of lost functional vision with the Argus II retinal prosthesis.
Markowitz M; Rankin M; Mongy M; Patino BE; Manusow J; Devenyi RG; Markowitz SN
Can J Ophthalmol; 2018 Feb; 53(1):14-22. PubMed ID: 29426432
[TBL] [Abstract][Full Text] [Related]
6. Effects of the Argus II Retinal Prosthesis System on the Quality of Life of Patients With Ultra-Low Vision Due to Retinitis Pigmentosa: Protocol for a Single-Arm, Mixed Methods Study.
White J; Knight L; da Cruz L; Stanga PE; Patrick H; Powell H; Berry L; Withers K; Carolan-Rees G; Jackson TL
JMIR Res Protoc; 2021 Jan; 10(1):e17436. PubMed ID: 33470946
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Results from an Epiretinal Prosthesis to Restore Sight to the Blind.
Ho AC; Humayun MS; Dorn JD; da Cruz L; Dagnelie G; Handa J; Barale PO; Sahel JA; Stanga PE; Hafezi F; Safran AB; Salzmann J; Santos A; Birch D; Spencer R; Cideciyan AV; de Juan E; Duncan JL; Eliott D; Fawzi A; Olmos de Koo LC; Brown GC; Haller JA; Regillo CD; Del Priore LV; Arditi A; Geruschat DR; Greenberg RJ;
Ophthalmology; 2015 Aug; 122(8):1547-54. PubMed ID: 26162233
[TBL] [Abstract][Full Text] [Related]
8. Retinal Prosthesis System for Advanced Retinitis Pigmentosa: A Health Technology Assessment.
Health Quality Ontario
Ont Health Technol Assess Ser; 2016; 16(14):1-63. PubMed ID: 27468325
[TBL] [Abstract][Full Text] [Related]
9. Improved performance and safety from Argus II retinal prosthesis post-approval study in France.
Delyfer MN; Gaucher D; Mohand-Saïd S; Barale PO; Rezaigua-Studer F; Ayello-Scheer S; Dollfus H; Dorn JD; Korobelnik JF; Sahel JA
Acta Ophthalmol; 2021 Nov; 99(7):e1212-e1221. PubMed ID: 33354943
[TBL] [Abstract][Full Text] [Related]
10. The Argus(®) II Retinal Prosthesis System.
Luo YH; da Cruz L
Prog Retin Eye Res; 2016 Jan; 50():89-107. PubMed ID: 26404104
[TBL] [Abstract][Full Text] [Related]
11. The First Epiretinal Implant for Hereditary Blindness in the Asia-Pacific Region.
Yanagihara RT; Yamane MLM; Kokame GT
Hawaii J Health Soc Welf; 2021 Nov; 80(11 Suppl 3):10-15. PubMed ID: 34820630
[TBL] [Abstract][Full Text] [Related]
12. Retina-electrode interface properties and vision restoration by two generations of retinal prostheses in one patient-one in each eye.
Yue L; Wuyyuru V; Gonzalez-Calle A; Dorn JD; Humayun MS
J Neural Eng; 2020 Apr; 17(2):026020. PubMed ID: 32131056
[TBL] [Abstract][Full Text] [Related]
13. An analysis of observer-rated functional vision in patients implanted with the Argus II Retinal Prosthesis System at three years.
Geruschat DR; Richards TP; Arditi A; da Cruz L; Dagnelie G; Dorn JD; Duncan JL; Ho AC; Olmos de Koo LC; Sahel JA; Stanga PE; Thumann G; Wang V; Greenberg RJ
Clin Exp Optom; 2016 May; 99(3):227-32. PubMed ID: 26804484
[TBL] [Abstract][Full Text] [Related]
14. Restoring Color Perception to the Blind: An Electrical Stimulation Strategy of Retina in Patients with End-stage Retinitis Pigmentosa.
Yue L; Castillo J; Gonzalez AC; Neitz J; Humayun MS
Ophthalmology; 2021 Mar; 128(3):453-462. PubMed ID: 32858064
[TBL] [Abstract][Full Text] [Related]
15. Effect of the electrode array-retina gap distance on visual function in patients with the Argus II retinal prosthesis.
Naidu A; Ghani N; Yazdanie MS; Chaudhary K
BMC Ophthalmol; 2020 Sep; 20(1):366. PubMed ID: 32943044
[TBL] [Abstract][Full Text] [Related]
16. Argus II retinal prosthesis system: An update.
Rachitskaya AV; Yuan A
Ophthalmic Genet; 2016 Sep; 37(3):260-6. PubMed ID: 26855177
[TBL] [Abstract][Full Text] [Related]
17. Visual BOLD Response in Late Blind Subjects with Argus II Retinal Prosthesis.
Castaldi E; Cicchini GM; Cinelli L; Biagi L; Rizzo S; Morrone MC
PLoS Biol; 2016 Oct; 14(10):e1002569. PubMed ID: 27780207
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of Structural and Functional MRI Acquisition with Unpowered Implants in Argus II Retinal Prosthesis Patients: A Case Study.
Cunningham SI; Shi Y; Weiland JD; Falabella P; Olmos de Koo LC; Zacks DN; Tjan BS
Transl Vis Sci Technol; 2015 Dec; 4(6):6. PubMed ID: 26693097
[TBL] [Abstract][Full Text] [Related]
19. The use of Argus® II retinal prosthesis by blind subjects to achieve localisation and prehension of objects in 3-dimensional space.
Luo YH; Zhong JJ; da Cruz L
Graefes Arch Clin Exp Ophthalmol; 2015 Nov; 253(11):1907-14. PubMed ID: 25547618
[TBL] [Abstract][Full Text] [Related]
20. The Detection of Motion by Blind Subjects With the Epiretinal 60-Electrode (Argus II) Retinal Prosthesis.
Dorn JD; Ahuja AK; Caspi A; da Cruz L; Dagnelie G; Sahel JA; Greenberg RJ; McMahon MJ;
JAMA Ophthalmol; 2013 Feb; 131(2):183-9. PubMed ID: 23544203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
